CYP2C19 (Gene)

Organism:

Homo sapiens

Synonyms:CPCJ, CYP2C, CYP2C19, CYPIIC17, CYPIIC19, ENTREZ:1557, HGNC:2621, MIM:124020, NM_000769, NP_000760, P450C2C, P450IIC19, cytochrome P450 family 2 subfamily C member 19

Omim:OMIM:124020

Id:eca93611-eb7c-5a56-b6c7-22ac3d1c667a

Hgnc:HGNC:2621

Entrez:1557

Ensembl:ENSG00000165841

Description:cytochrome P450 family 2 subfamily C member 19

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CYP2C19's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CYP2C19.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CYP2C19.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CYP2C19.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CYP2C19.

Results found

Linked to

	Label	Description
	GSE208350 H-7 Huh-7 JHH-7 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE242333 sorafenib 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE125862 2 V 0 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 13 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 4 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434,GSE202438 13 V 1 TALAZOPARIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE235701 GSE261434 enasidenib 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE242333 0 V 2 SORAFENIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 14 V 8 NICOTINAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

GSE208350 H-7 Huh-7 JHH-7 0 v 8 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE242333 sorafenib 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE125862 2 V 0 DEXAMETHASONE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 8 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 13 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE48812 sulforaphane 4 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434,GSE202438 13 V 1 TALAZOPARIB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE235701 GSE261434 enasidenib 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE242333 0 V 2 SORAFENIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE233679 14 V 8 NICOTINAMIDE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.